Target intelligence / Profile preview

BCL6 corepressor pseudogene 1 (BCORP1)

Target
BCORP1
Molecular classification
Other
01

Overview

BCL6 corepressor pseudogene 1 (BCORP1) is classified as a pseudogene related to the BCL6 corepressor gene (BCOR). Pseudogenes are DNA sequences resembling functional genes but are typically non-functional; they do not code for functional proteins and do not have the regulatory activities of their parental genes. There is no evidence supporting a direct functional role, target activity, or disease association for BCORP1. All available research and biomedical databases focus on BCOR (BCL6 corepressor) as a biologically important gene/protein, not BCORP1, and the latter should not be confused with the functional BCL6 corepressor or its protein products[2][3]. - BCORP1 is a pseudogene and not an active therapeutic target, enzyme, receptor, or other molecularly active biomolecule. - Its naming similarity to "BCOR," which is the true BCL6 corepressor, sometimes leads to confusion, but BCORP1 itself does not produce functional protein and is not involved in biological pathways or disease processes[2][3]. - No information exists on drug interactions, biological function, or disease roles for BCORP1; all such information pertains to BCOR and not its pseudogenes[2][3]. If information was sought on *BCL6 corepressor (BCOR)* instead of *BCL6 corepressor pseudogene 1 (BCORP1)*, the target would be a functionally significant transcriptional corepressor involved in development and disease, but that does not apply to BCORP1[2][3].

Other names
BCORL2putative BCoR-like protein 2BCL-6 corepressor pseudogene 1BCL-6 corepressor-like protein 2BCL6 co-repressor pseudogeneBCL6 co-repressor-like 2BCL6 corepressor-like 2BCoR-like protein 2BCORP1LOC105377223

Beyond the preview

Go deeper on BCL6 corepressor pseudogene 1 (BCORP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL6 corepressor pseudogene 1 (BCORP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call